Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Damaging mitochondrial DNA in mice speeds up aging due to increased reactive oxygen species, not through the p53/p21 pathway.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Phyto-vesicles of β-sitosterol may effectively treat hair loss.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The woman's hair loss was mainly due to stress and low iron levels, and her hair grew back after treatment.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

Ethosomes are a promising way to deliver drugs through the skin.